2021 Cash Bonus Plan Summary

EX-10.1 2 ex_248728.htm EXHIBIT 10.1 ex_248728.htm

Exhibit 10.1


2021 Cash Bonus Plan Summary


Target bonuses for named executive officers of AcelRx Pharmaceuticals, Inc. (the “Company”) under the 2021 Cash Bonus Plan (the “Plan”) will range from 35% to 60% of such executive’s 2021 base salary. The target bonuses for the Company’s named executive officers for 2021 are as follows:




Bonus %

Vincent Angotti

Chief Executive Officer


Pamela Palmer, M.D., Ph.D.

Chief Medical Officer


Raffi Asadorian

Chief Financial Officer


Badri Dasu

Chief Engineering Officer



Mr. Angotti’s cash bonus under the Plan shall be based 100% on the achievement of the 2021 corporate objectives.  The cash bonuses under the Plan for all other named executive officers shall be based 40% on the achievement of his or her individual performance goals, as determined by the Board, and 60% on the achievement of the 2021 corporate objectives. The named executive officers’ actual bonuses may exceed 100% of target in the event performance exceeds the predetermined goals.